Charles Newton/Lancet Neurol

Epidemiology, causes, and treatment of epilepsy in sub-Saharan Africa.Ba-Diop A, Marin B, Druet-Cabanac M, Ngoungou EB, Newton CR, Preux PM
Lancet Neurol, (2014). 13:1029-44

Prevalence of active convulsive epilepsy in sub-Saharan Africa and associated risk factors: cross-sectional and case-control studies.Ngugi AK, Bottomley C, Kleinschmidt I, Wagner RG, Kakooza-Mwesige A, Ae-Ngibise K, Owusu-Agyei S, Masanja H, Kamuyu G, Odhiambo R, Chengo E, Sander JW, Newton CR, Seeds group
Lancet Neurol, (2013). 12:253-63

Risk factors associated with the epilepsy treatment gap in Kilifi, Kenya: a cross-sectional study.Mbuba CK, Ngugi AK, Fegan G, Ibinda F, Muchohi SN, Nyundo C, Odhiambo R, Edwards T, Odermatt P, Carter JA, Newton CR
Lancet Neurol, (2012). 11:688-96

Incidence and outcome of convulsive status epilepticus in Kenyan children: a cohort study.Sadarangani M, Seaton C, Scott JA, Ogutu B, Edwards T, Prins A, Gatakaa H, Idro R, Berkley JA, Peshu N, Neville BG, Newton CR
Lancet Neurol, (2008). 7:145-50

Active convulsive epilepsy in a rural district of Kenya: a study of prevalence and possible risk factors.Edwards T, Scott AG, Munyoki G, Odera VM, Chengo E, Bauni E, Kwasa T, Sander LW, Neville BG, Newton CR
Lancet Neurol, (2008). 7:50-6

Pathogenesis, clinical features, and neurological outcome of cerebral malaria.Idro R, Jenkins NE, Newton CR
Lancet Neurol, (2005). 4:827-40